Is CYP1A2 useful for blood sugar?

Whether CYP1A2 is useful for blood sugar management is not well supported by current evidence. CYP1A2 is a cytochrome P450 enzyme primarily involved in metabolizing caffeine and estrogens. Some studies suggest that the rs762551 variant (slow vs. fast metabolizer) may modestly modulate glucose tolerance or diabetes risk when combined with high caffeine intake. However, effect sizes are small, findings are inconsistent, and lifestyle factors (caffeine dose, smoking, hormonal status) dominate. There is no robust evidence to recommend CYP1A2 genotyping for routine blood sugar optimization. Claims linking this gene to personalized diet advice are largely marketing-driven rather than clinically actionable. Caveat: genetic testing alone cannot replace standard glycemic markers (HbA1c, fasting glucose) or medical guidance. Evidence: mixed (mechanistic + small human studies).